Search - tctmd.com

Displaying 621 - 640 of 983

Sort: Relevancy | Date

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 15, 2019

Presentation TVT 2019

Use of a New-Generation Transcatheter Heart Valve Facilitating Valve-in-Valve TAVR and Bioprosthetic Valve Fracture in a Patient at High Risk of Coronary Obstruction

Presenter: Mark Hensey

June 14, 2019

Presentation TVT 2019

Left Main Coronary Artery Balloon Occlusion — A Simple Maneuver to Assess the Need of BASILICA

Presenter: Albert Chan

June 14, 2019

Presentation TVT 2019

Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study

Presenter: Gilbert Tang

June 14, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Stanley Chetcuti

June 13, 2019

Presentation TVT 2019

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Presenter: Philipp Blanke

June 13, 2019

Presentation TVT 2019

Coronary Access and Coronary Obstruction: The Achilles' Heel of Redo TAVR?

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Philipp Blanke

June 13, 2019

Presentation TVT 2019

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Presenter: Luis Dallan

June 13, 2019

Presentation TVT 2019

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Presenter: Gilbert Tang

June 13, 2019

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

Todd Neale

June 12, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

Advertisement

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Use of a New-Generation Transcatheter Heart Valve Facilitating Valve-in-Valve TAVR and Bioprosthetic Valve Fracture in a Patient at High Risk of Coronary Obstruction

Left Main Coronary Artery Balloon Occlusion — A Simple Maneuver to Assess the Need of BASILICA

Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Coronary Access and Coronary Obstruction: The Achilles' Heel of Redo TAVR?

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Potential Warning Signs Seen for NOAC Use After TAVR

TAVR Operators: Can One Do It All or Are Two Still Justified?

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

TCTMD’s Top 10 Most Popular Stories for May 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content